A2 BIO
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97980850
- Registration number
- 8119042
- Mark type
- Design + words
- Filed
- 14 Oct 2021
- Published for opposition
- 04 Apr 2023
- Registered
- 27 Jan 2026
- Attorney of record
- Joi A. White
Goods and services
- Class 005 — Pharmaceuticals: Therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer; biotherapeutics for the treatment and prevention of cancer; medicines for the treatment and prevention of cancer; pharmaceutical products for the treatment and prevention of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer; therapeutics and cell therapies in the nature of cells, proteins and protein complexes for the treatment of cancer; engineered cell therapies in the nature of cells, proteins and protein complexes for medical purposes, namely, the treatment and prevention of cancer; engineered cell therapy platforms consisting of modified cells, cell receptors, proteins and protein complexes; cell platforms consisting of modified cells, cell receptors, proteins and protein complexes for the treatment and prevention of cancer; technology platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer; platform for autologous and allogeneic cell manufacturing; therapeutics and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer; gene therapy products, namely, genetically engineered tissues for transplant purposes;
- Class 040 — Treatment of materials: Custom manufacturing of therapeutics, biotherapeutics, medicines, and pharmaceuticals; manufacturing of cells, therapeutics and cell therapies for the treatment and prevention of cancer; biomanufacturing for others, namely, manufacturing of cells, therapeutics and cell therapies for the treatment and prevention of cancer using biological cells in the manufacturing process; cell therapy manufacturing for others; autologous and allogeneic cell manufacturing for others; manufacturing services for others in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing and engineering of biological cells, cellular targets, proteins, and antibodies for others for treatment and prevention of cancer;
- Class 042 — Scientific and technological services: Medical research services; pharmaceutical and biopharmaceutical research and development services; provision of medical and scientific research information in the fields of therapeutics, biotherapeutics, medicines, pharmaceuticals; identification and development of therapeutic targets for others for the treatment and prevention of cancer; development of therapeutics and cell therapies for treatment and prevention of cancer; research and development of therapeutics and cell therapies targeting targets lost for the treatment and prevention of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; scientific research and development services; providing scientific information relating to treatment and prevention of cancer; research, development, engineering and testing services in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; medical laboratory services, namely, tissue material processing and analysis in the field of autologous and allogeneic biologic preparations for medical use; biotechnology laboratory services; scientific and medical laboratory services; genetic engineering services;
Owner
- A2 Biotherapeutics, Inc., Agoura Hills, CA, US
- A2 Biotherapeutics, Inc., Agoura Hills, CA, US
- A2 Biotherapeutics, Inc., Agoura Hills, CA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 May 2025 — USE AMENDMENT FILED
- 10 Nov 2025 — DIVISIONAL PROCESSING COMPLETE
- 30 May 2025 — DIVISIONAL REQUEST RECEIVED
- 30 May 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 07 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 20 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 4 GRANTED
- 19 May 2025 — SOU EXTENSION 4 FILED